Bio-Rad Laboratories, Inc. (BIO) financials

Bio-Rad Laboratories, Inc. (BIO) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Bio-Rad Laboratories, Inc. reported revenue of $2.58B, up 0.7% year over year, net income of $760M, diluted EPS of $27.85 and free cash flow of $375M.

Revenue (fiscal 2025)

$2.58B

Revenue growth (fiscal 2025)

0.7%

Net income (fiscal 2025)

$760M

Diluted EPS (fiscal 2025)

$27.85

Free cash flow (fiscal 2025)

$375M

Bio-Rad Laboratories, Inc. files with the U.S. Securities and Exchange Commission under CIK 0000012208, classified as Laboratory Analytical Instruments.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.